Mutual of America Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.98M | Sell |
|
|||||
|
2025
Q2 | $5.2M | Buy |
|
|||||
|
2025
Q1 | $3.68M | Buy |
|
|||||
|
2024
Q4 | $415K | Sell |
|
|||||
|
2024
Q3 | $529K | Buy |
|
|||||
|
2024
Q2 | $369K | Hold |
|
|||||
|
2024
Q1 | $227K | Hold |
|
|||||
|
2023
Q4 | $291K | Sell |
|
|||||
|
2023
Q3 | $299K | Hold |
|
|||||
|
2023
Q2 | $320K | Buy |
|
|||||
|
2023
Q1 | $327K | Hold |
|
|||||
|
2022
Q4 | $388K | Sell |
|
|||||
|
2022
Q3 | $342K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $263K | Sell |
|
|||||
|
2020
Q4 | $250K | Sell |
|
|||||
|
2020
Q3 | $295K | Hold |
|
|||||
|
2020
Q2 | $300K | Buy |
|
|||||
|
2020
Q1 | $164K | Hold |
|
|||||
|
2019
Q4 | $173K | Sell |
|
|||||
|
2019
Q3 | $139K | Hold |
|
|||||
|
2019
Q2 | $126K | Hold |
|
|||||
|
2019
Q1 | $162K | Sell |
|
|||||
|
2018
Q4 | $141K | Hold |
|
|||||
|
2018
Q3 | $169K | Hold |
|
|||||
|
2018
Q2 | $191K | Buy |
|
|||||
|
2018
Q1 | $116K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.16M | Hold |
|
|||||
|
2016
Q2 | $948K | Buy |
|
|||||
|
2016
Q1 | $994K | Sell |
|
|||||
|
2015
Q4 | $2.04M | Buy |
|
|||||
|
2015
Q3 | $1.73M | Hold |
|
|||||
|
2015
Q2 | $2.58M | Sell |
|
|||||
|
2015
Q1 | $2.43M | Sell |
|
|||||
|
2014
Q4 | $2.32M | Sell |
|
|||||
|
2014
Q3 | $3.26M | Hold |
|
|||||
|
2014
Q2 | $2.64M | Sell |
|
|||||
|
2014
Q1 | $2.98M | Sell |
|
|||||
|
2013
Q4 | $3.43M | Sell |
|
|||||
|
2013
Q3 | $3.8M | Sell |
|
|||||
|
2013
Q2 | $3.16M | Buy |
|